SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-211860
Filing Date
2022-08-04
Accepted
2022-08-04 08:08:00
Documents
17
Period of Report
2022-08-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d346334d8k.htm   iXBRL 8-K 49036
2 EX-2.1 d346334dex21.htm EX-2.1 438272
3 EX-99.1 d346334dex991.htm EX-99.1 33683
8 GRAPHIC g346334g0804124456891.jpg GRAPHIC 4469
9 GRAPHIC g346334g0804124457094.jpg GRAPHIC 3035
  Complete submission text file 0001193125-22-211860.txt   808381

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amgn-20220803.xsd EX-101.SCH 3907
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20220803_def.xml EX-101.DEF 13281
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20220803_lab.xml EX-101.LAB 21863
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20220803_pre.xml EX-101.PRE 14178
11 EXTRACTED XBRL INSTANCE DOCUMENT d346334d8k_htm.xml XML 5145
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 221134812
SIC: 2836 Biological Products, (No Diagnostic Substances)